Quarterly Update to the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS)

April 26, 2019

Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal

APRIL 19, 2019

FDA MedWatch: Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets

November 30, 2018

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets

 

FDA MedWatch: SGLT2(sodium-glucose cotransporter-2) Inhibitors for Diabetes: Drug Safety Communication

August 30, 2018

FDA MedWatch: Voluntary Nationwide Recall of Hydrochlorothiazide Tablets USP 12.5 Mg Due to Labeling Mix-up

August 30, 2018

Accord Healthcare Inc. is voluntarily recalling One lot (Lot PW05264 – 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide Tablets USP, 12.5 mg, to the consumer level.

FDA MedWatch Class 2 Device Recall: AMIA Automated PD Cycler

Date Initiated by Firm

July 12, 2018

Create Date

August 02, 2018

FDA MedWatch: AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam

August 1, 2018

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Fluoroquinolone Antibiotics: FDA Requires Labeling Changes

ISSUE: FDA is strengthening the current warnings in the prescribing information that fluoroquinolone antibiotics may cause significant decreases in blood sugar and certain mental health side effects. 

Pages